![Mary Gray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Gray
Director/Board Member at
KEROS THERAPEUTICS, INC.
Net worth: 143 643 $ as of 2026-05-30
Profile
Mary Ann Gray is the founder of Gray Strategic Advisors LLC, founded in 2003, serving as President since 2003.
Current jobs include Independent Director at BioAtla, Inc. since 2020, Independent Director at Keros Therapeutics, Inc. since 2020, and Independent Director at Compass Therapeutics, Inc. since 2022.
Former jobs include Independent Director at Catalent JNP, Inc. from 2016 to 2018; Lead Independent Director at Dyax Corp.
from 2011 to 2016; Director at Telik, Inc. in 2009; Independent Director at ACADIA Pharmaceuticals, Inc. from 2005 to 2016; Independent Director at TetraLogic Pharmaceuticals Corp.
from 2014 to 2016; Director at Galena Biopharma, Inc. from 2016 to 2017; Independent Director at Seneca Biopharma, Inc.; Director at Apthera, Inc. from 2009 to 2011; Director at rEVO Biologics, Inc. from 2007 to 2009; Independent Director at Sarepta Therapeutics, Inc. from 2018 to 2022; Independent Director at Palisade Bio, Inc. from 2019 to 2024; Independent Director at Rapt Therapeutics, Inc. from 2019 to 2026; Director at Senomyx, Inc. in 2018; Senior Scientist at Poniard Pharmaceuticals, Inc.; Senior Scientist at Schering-Plough Corp.; Principal at Raymond James & Associates, Inc.; Advisor at Burrill LLC; Portfolio Manager at Federated Hermes Kaufmann Fund from 1999 to 2003; Principal at Kidder Peabody; Fund Manager at Federated Investment Management Co. from 1999 to 2003; Principal at Warburg Dillon Read LLC.
Education includes an undergraduate degree from the University of South Carolina in 1973 and a doctorate from the University of Vermont in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-02 | 12,392 ( 0.06% ) | 139 410 $ | 2026-05-30 | |
BIOATLA, INC. 0.06% | 2026-03-30 | 1,077 ( 0.06% ) | 4 233 $ | 2026-05-30 |
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Mary Gray active positions
| Companies | Position | Start |
|---|---|---|
| BIOATLA, INC. | Director/Board Member | 2020-11-30 |
| KEROS THERAPEUTICS, INC. | Director/Board Member | 2020-12-16 |
| COMPASS THERAPEUTICS, INC. | Director/Board Member | 2022-04-24 |
Gray Strategic Advisors LLC | Founder | 2003-08-31 |
Former positions of Mary Gray
| Companies | Position | End |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Director/Board Member | 2026-03-02 |
| PALISADE BIO, INC. | Director/Board Member | 2024-03-03 |
| SAREPTA THERAPEUTICS, INC. | Director/Board Member | 2022-06-01 |
| SENOMYX INC. | Director/Board Member | 2018-11-30 |
| JUNIPER PHARMACEUTICALS INC | Director/Board Member | 2018-07-31 |
Training of Mary Gray
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
27
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 27 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Raymond James & Associates, Inc.
 Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Discovers and develops novel flavors and taste modulators for the packaged food and beverage industry | Consumer Non-Durables |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Health Technology |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
Federated Hermes Kaufmann Fund
 Federated Hermes Kaufmann Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Kidder Peabody
 Kidder Peabody Investment Banks/BrokersFinance Engaged in investment banking, brokerage and trading | Finance |
Federated Investment Management Co.
 Federated Investment Management Co. Investment ManagersFinance FIMCO offers a broad range of investment strategies, from liquidity solutions to high active share global and regional equities to active credit and private markets. Each investment team works with Responsible Investing Office personnel as they look to incorporate proprietary ESG tools and insights from our in-house engagement and stewardship team, EOS at Federated Hermes. | Finance |
Warburg Dillon Read LLC
 Warburg Dillon Read LLC Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
Apthera, Inc.
 Apthera, Inc. Medical/Nursing ServicesHealth Services Develops a pipeline of peptide-based immunotherapies for cancers | Health Services |
Gray Strategic Advisors LLC | |
BioAtla, Inc.
 BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
- Stock Market
- Insiders
- Mary Gray
